Organovo Holdings Inc. Moving to Nasdaq Exchange
Original article posted on the San Diego Business Journal .
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, is moving its stock to the biotech-heavy Nasdaq exchange from the NYSE MKT.
“Nasdaq is home to many of the world’s most innovative biotechnology and health care companies and is a natural fit for Organovo,” CEO Keith Murphy said in a statement. “We believe that this move will work to the long-term benefit of our shareholders.”
The company’s stock will begin trading on Nasdaq on Aug. 8 under the stock symbol ONVO. Organovo’s common stock will continue to trade on the NYSE MKT until the market close on Aug. 5.